Skip to main content
. 2023 Apr 19;15(2):e12430. doi: 10.1002/dad2.12430

TABLE 1.

Baseline characteristics.

Description MCI N = 300 MILD N = 317 Total N = 617
Age, mean (SD), years 70.3 (7.4) 71.7 (8.0) 71.0 (7.8)
Sex, n (%) female 158 (52.7) 167 (52.7) 325 (52.7)
Race, n (%) White 259 (86.3) 279 (88.0) 538 (87.2)
Time since AD diagnosis, mean (SD), years 1.0 (1.3) 1.5 (2.3) 1.3 (1.9)
Time since first symptoms, mean (SD), years 2.7 (2.4) 3.2 (3.1) 3.0 (2.8)
Had any comorbid conditions, n (%) 263 (87.7) 272 (85.8) 535 (86.7)
Depression, n (%) 94 (35.7) 110 (40.4) 204 (38.1)
Sleep disorders, n (%) 57 (21.7) 72 (26.5) 129 (24.1)
Number of comorbidities, mean (SD) 2.3 (1.5) 2.3 (1.7) 2.3 (1.6)
CFI‐Study partner version (range 20–100) a 47.0 (14.0) 63.7 (13.4) 55.6 (16.0)
MMSE (range 0–30) b , mean (SD) 27.4 (1.8) 24.4 (2.8) 25.9 (2.8)

Abbreviations: AD, Alzheimer's disease; CFI, Cognitive Function Index; MCI, mild cognitive impairment due to Alzheimer's disease; MILD, mild dementia due to Alzheimer's disease; MMSE, Mini‐Mental State Examination; n, number of patients in each category; N, total number of patients in the cohort; SD, standard deviation.

a

Higher scores equal poorer status.

b

Lower scores equal poorer status.